• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

type 1 diabetes

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

by Fred Pennic 03/13/2023 Leave a Comment

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

What You Should Know: - Sanofi has agreed to acquire Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), for $25.00 per share in cash, representing an equity value of approximately $2.9B. - The acquisition is a strategic fit for Sanofi at the intersection of the company’s growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet
Read More

The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank

by Girisha Fernando, CEO and Founder of Lyfegen 11/15/2022 Leave a Comment

The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank

Advanced medical research has brought us to the point where many serious conditions can potentially be treated and even cured - with people who have essentially faced a lifetime of being incapacitated finally able to conduct normal lives. Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. The latest example–and most expensive medication to date– is bluebird bio’s recently-approved $2.8 million gene therapy to treat a rare blood
Read More

At-Home Digital Health Innovations Transforming Diabetes Care

by Mark Clements, MD, PhD, CPI, FAAP, Chief Medical Officer, Glooko, Inc. 04/04/2022 Leave a Comment

At-Home Digital Health Innovations Transforming Diabetes Care

If you’re looking for a silver lining in the COVID-19 dark cloud still enshrouding the world, consider this: The pandemic has turbocharged widespread acceptance of at-home digital health solutions. Forced to function in a world of social distancing, healthcare providers and physicians have quickly discovered how easily telehealth visits, remote patient monitoring (RPM) and digital therapeutics can improve patient care.  Many of these digital health innovations are designed to address
Read More

Early Use of Diabetes Technology Drives Better Patient Outcomes in Kids

by David Maahs, MD, Division Chief of Pediatric Endocrinology, Stanford Children’s Health 03/22/2022 Leave a Comment

Early Use of Diabetes Technology Drives Better Patient Outcomes in Kids

A recent study from Stanford found that pediatric patients with rapid access to continuous glucose monitoring soon after a type 1 diabetes diagnosis had healthier blood sugar values than an earlier group of patients who weren’t given the monitors near the time of diagnosis.  The research provides an example of how the healthcare industry is evolving to use technology: It provides more frequent touchpoints with caregivers, makes quality care available to a larger number of patients, and
Read More

Medtronic Launches Initiatives to Address Health Equity for People of Color Living with Diabetes

by Jasmine Pennic 04/07/2021 Leave a Comment

diabetes management qualcomm medtronic diabetes

What You Should Know: - Medtronic announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities. New Partnerships and Research Efforts Prioritized Over the Next Three Years to Address Health Disparities Details of each partnership, as well as additional
Read More

Data-Driven Future: Impact of Machine Learning on Diabetes Management

by Athar Siddiqui: Global Strategy Lead, Digital Connected Solutions - Ascensia Diabetes Care 03/02/2021 Leave a Comment

Impact of Machine Learning on Diabetes

“Information technology and business are becoming inextricably interwoven. I don't think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare.  The ability to collect, analyze, and use data is becoming ubiquitous with many of healthcare’s most exciting advancements. Whether it’s Google’s DeepMind using artificial intelligence (AI) to help
Read More

NIH Funds First Nationwide Rare and Atypical Diabetes Network

by Fred Pennic 10/02/2020 Leave a Comment

NIH Funds First Nationwide Rare and Atypical Diabetes Network

What You Should Know: - NIH awards funding for Rare and Atypical Diabetes Network, or RADIANT that will seek to discover the cause of several unusual forms of diabetes. - RADIANT plans to screen about 2,000 people with unknown or atypical forms of diabetes that do not fit the common features of type 1 and type 2 diabetes. The National Institute of Health (NIH), announced this week it is funding a nationwide study with The Rare and Atypical Diabetes Network (RADIANT) that will seek
Read More

FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes

by Jasmine Pennic 09/02/2020 Leave a Comment

FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes

What You Should Know: - Medtronic announced the U.S. Food and Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump system with smartphone connectivity and an expanded age indication to patients with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for an automated insulin pump system.  - The new MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app (compatible with both iPhone and Android), and Roche Accu-Chek®
Read More

DreaMed Diabetes Supports Research on Efficacy of Virtual Diabetes Care

by Fred Pennic 08/10/2020 Leave a Comment

diabetes management qualcomm medtronic diabetes

What You Should Know: - DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.  - DreaMed uses AI-powered technology to seamlessly treat patients remotely with its virtual diabetes management service by
Read More

DreaMed Launches Virtual Diabetes Clinic to Help Type-1 Diabetics Control Their Condition in Quarantine

by Jasmine Pennic 04/15/2020 Leave a Comment

DreaMed Launches AI-Powered Virtual Clinic to Help Type-1 Diabetics Control Their Condition in Quarantine

What You Should Know: - As COVID-19 spreads, DreaMed Diabetes unveils virtual diabetes clinic software to treat people with type 1 diabetes remotely. - The virtual clinic utilizes Dreamed Diabetes’ AI-powered solution, to improve the insulin management treatment by analyzing the patient’s insulin and glucose data in the platform's algorithm and to remotely advise doctors on treatment. - According to the CDC people with chronic medical conditions, including diabetes, have a higher risk
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |